Invention Grant
- Patent Title: Anti-bacterial compositions and uses thereof
-
Application No.: US16491176Application Date: 2018-03-07
-
Publication No.: US11690885B2Publication Date: 2023-07-04
- Inventor: Cindy Fevre , Hélène Blois , Mathieu Medina
- Applicant: PHERECYDES PHARMA
- Applicant Address: FR Romainville
- Assignee: PHERECYDES PHARMA
- Current Assignee: PHERECYDES PHARMA
- Current Assignee Address: FR Romainville
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP 305245 2017.03.08
- International Application: PCT/EP2018/055629 2018.03.07
- International Announcement: WO2018/162566A 2018.09.13
- Date entered country: 2019-09-05
- Main IPC: A61K35/76
- IPC: A61K35/76 ; A61P31/04 ; C12N7/00 ; A01N63/40 ; C12Q1/18 ; C07K14/005 ; A61K38/00
Abstract:
The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Staphylococcus aureus strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy and as companion diagnostic.
Public/Granted literature
- US20200030392A1 PHAGE THERAPY Public/Granted day:2020-01-30
Information query
